ClinicalTrials.gg
CompletedNCT07170709WBV-BMRUpdated Oct 26, 2026

WBV Reflex Latency and Mechanical Load

An interventional study of Whole-Body Vibration in Whole-body Vibration, Healthy Volunteers (HV) and Muscle Contraction, sponsored by Selim Sezikli. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Selim Sezikli · Not applicable, Interventional, and Basic science

How we know

Updated Oct 26, 2026Eligibility revisedEnrollment updated+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

This study aims to investigate how the magnitude of mechanical loading affects reflex latency patterns induced by whole-body vibration (WBV). WBV can trigger two types of reflexes: the tonic vibration reflex (TVR) and the bone myoregulation reflex (BMR), which may be influenced by load-bearing condition. The study will include healthy adult volunteers aged 18-40 years. Reflex responses will be recorded from the soleus muscle using surface EMG during both WBV. Different conditions of mechanical loading (i.e., standing on one foot, both feet) and vibration frequencies (30-36 Hz) will be tested. The main outcome will be the latency of the reflex responses, which will help distinguish between TVR and BMR activation. The goal is to better understand how mechanical load modifies reflex response timing and to characterize the underlying afferent pathways. This knowledge may contribute to optimizing vibration-based rehabilitation strategies.

Read the detailed description

This study investigates how the magnitude of mechanical loading alters reflex latency patterns during whole-body vibration (WBV), focusing specifically on the tonic vibration reflex (TVR) and the bone myoregulation reflex (BMR). Experimental data suggest that WBV may activate different reflex mechanisms depending on the level of postural loading, frequency, and amplitude of the vibration. Previous studies have shown that low-amplitude WBV tends to activate TVR under voluntary contraction, while higher mechanical loads and neutral standing posture are more likely to induce BMR.

Surface electromyography (sEMG) recordings will be obtained from the soleus muscle during vibration stimuli applied at different frequencies (30, 32, 34, and 36 Hz). Recordings will be taken under multiple loading conditions: standing on both feet, standing on one foot. Reflex latency will be calculated using cumulative averaging techniques, and data will be analyzed offline using Python 3.11, SPSS v25, R 4.6.1 software.

Findings from this study may contribute to a deeper understanding of reflex integration during vibratory stimulation and inform future neurorehabilitation protocols that utilize WBV as a therapeutic modality.

02

Conditions studied

  • Whole-body Vibration
  • Healthy Volunteers (HV)
  • Muscle Contraction
  • Postural Balance
  • Electromyography

Keywords

  • Whole-Body Vibration
  • Tonic Vibration Reflex
  • Bone Myoregulation Reflex
  • Reflex Latency
  • Postural Reflexes
  • Surface Electromyography
  • Mechanical Loading
  • Healthy Volunteers
  • Neuromuscular Physiology
03

In context

Lead sponsor

Selim Sezikli is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Oct 26, 2026. See what changed

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18 and 40 years
  • Healthy adult volunteers with no known neurological or musculoskeletal disorders
  • Able to provide
  • Willing to comply with the procedures of the study, including EMG and vibration exposure

Exclusion criteria

Exclusion Criteria:

  • History of any neurological condition (e.g., peripheral neuropathy, spinal cord injury, stroke)
  • Musculoskeletal injury or surgery involving the lower extremities
  • Use of medications affecting neuromuscular function
  • Pregnancy
  • Presence of implanted electronic devices (e.g., pacemaker)
  • Known intolerance to vibration exposure
  • History of vertigo
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Other
    Low load first

    Participants first underwent low-load whole-body vibration (bipedal stance, 1.2 mm peak-to-peak platform displacement), followed by high-load whole-body vibration (unipedal stance, 2.2 mm peak-to-peak displacement). Within each condition, 10-s vibration blocks were delivered at 30, 32, 34 and 36 Hz in randomized order. Participants stood in quiet upright stance with the hands resting lightly on a fixed bar.

    Device: Whole-Body Vibration

  • Other
    High load first

    Participants first underwent high-load whole-body vibration (unipedal stance, 2.2 mm peak-to-peak platform displacement), followed by low-load whole-body vibration (bipedal stance, 1.2 mm peak-to-peak displacement). Within each condition, 10-s vibration blocks were delivered at 30, 32, 34 and 36 Hz in randomized order. Participants stood in quiet upright stance with the hands resting lightly on a fixed bar.

    Device: Whole-Body Vibration

Interventions

  • DeviceWhole-Body Vibration

    Participants will receive whole-body vibration (WBV) at 30-36 Hz under different mechanical loading conditions (e.g., standing on one foot, both feet,). Vibration-induced reflex responses will be recorded from the soleus muscle using surface electromyography. The intervention is designed to evaluate latency differences between tonic vibration reflex (TVR) and bone myoregulation reflex (BMR) under controlled biomechanical scenarios.

    Also known as: WBV, Reflex Latency Vibration Protocol

06

What researchers measure

Primary outcomes

  1. Reflex latency (milliseconds) in the soleus muscle during vibration stimulation

    Reflex latency will be calculated based on surface EMG recordings from the soleus muscle during whole-body vibration at frequencies of 30-36 Hz. Latency will be analyzed using cumulative averaging techniques and expressed in milliseconds.

    Time frame: Day 1 (single-session, during each experimental condition)

Secondary outcomes

  1. EMG amplitude of reflex response in the soleus muscle during vibration stimulation

    The magnitude of EMG response during whole-body vibration will be recorded from the soleus muscle. Reflex amplitude differences will be analyzed across various postural loading conditions to evaluate suppression or facilitation effects.

    Time frame: Day 1 (single-session, during each experimental condition)

  2. Reflex type classification (TVR vs BMR) based on latency and mechanical load

    Reflex responses will be categorized as tonic vibration reflex (TVR) or bone myoregulation reflex (BMR) based on latency values and mechanical loading condition. Classification will be supported by comparisons of reflex latency and EMG suppression patterns across experimental conditions.

    Time frame: Day 1 (single-session, during each experimental condition)

  3. Reflex latency variability under different mechanical loading conditions

    Variability in reflex latency will be assessed across different postural load conditions (e.g., single-leg, double-leg, prone) to determine how load magnitude influences the consistency of reflex timing. Standard deviation and coefficient of variation will be calculated for each condition.

    Time frame: Day 1 (single-session, during each experimental condition)

  4. Effect of vibration frequency on reflex latency and amplitude

    Reflex latency and EMG amplitude will be compared across vibration frequencies (30, 32, 34, and 36 Hz) to investigate frequency-dependent modulation of neuromuscular responses in the soleus muscle.

    Time frame: Day 1 (single-session, during each experimental condition)

  5. Reflex persistence during whole-body vibration

    Persistence was defined as the proportion of mechanical vibration cycles eliciting a soleus electromyographic reflex response within a 10-s analysis window. Persistence was compared between low- and high-load conditions and across vibration frequencies of 30, 32, 34 and 36 Hz.

    Time frame: Day 1 (single-session, during each experimental condition)

  6. Phase-locking strength between the vibration cycle and the soleus reflex response

    Phase-locking strength was quantified as pairwise phase consistency (PPC) between the phase of the platform acceleration signal and soleus electromyographic reflex events. PPC was compared between low- and high-load conditions and across vibration frequencies of 30, 32, 34 and 36 Hz.

    Time frame: Day 1 (single-session, during each experimental condition)

07

Study locations

1 site
  • Istanbul Physical Medicine and Rehabilitation Training and Research Hospital
    Istanbul, Istanbul 34186, Turkey (Türkiye)
08

References and documents

Publications

  • Karacan I, Turker KS. Exploring neuronal mechanisms of osteosarcopenia in older adults. J Physiol. 2026 Jan;604(2):672-688. doi: 10.1113/JP285666. Epub 2024 Aug 9. PubMed 39119811 ↗
  • Karacan I, Cidem M, Yilmaz G, Sebik O, Cakar HI, Turker KS. Tendon reflex is suppressed during whole-body vibration. J Electromyogr Kinesiol. 2016 Oct;30:191-5. doi: 10.1016/j.jelekin.2016.07.008. Epub 2016 Jul 25. PubMed 27485766 ↗
  • Karacan I, Cidem M, Cidem M, Turker KS. Whole-body vibration induces distinct reflex patterns in human soleus muscle. J Electromyogr Kinesiol. 2017 Jun;34:93-101. doi: 10.1016/j.jelekin.2017.04.007. Epub 2017 Apr 24. PubMed 28457998 ↗

Individual participant data

Plan to share: Yes — Following publication of the main study results, de-identified individual participant data (IPD) and relevant supporting documents will be made available to qualified researchers upon submission of a valid research proposal. Data will be provided exclusively for research purposes and under a formal data sharing agreement.

Supporting information: Study protocol

Time frame: Data will be available beginning 6 months after the primary publication and will remain accessible for 5 years. Access will be granted on a case-by-case basis following review of a research proposal and execution of a formal data-sharing agreement.

Access criteria: Access will be limited to qualified researchers who submit a request for a research project that has received prior ethical approval and who agree to comply with the study's confidentiality principles. Data access will be granted through a formal data-sharing agreement executed between the requesting researcher and the study sponsor or relevant institution. The agreement will specify the intended purpose of data use, the duration of access, and the confidentiality obligations. Shared data will consist of de-identified individual participant data (IPD), with all potentially identifying information removed. Supporting documents such as the study protocol, statistical analysis plan, and analytic code will also be provided to promote research transparency.

Data sharing details ↗ · istanbulftr.saglik.gov.tr

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2025 to primary completion in Sep 2025, 0 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 29, 2025
First posted
Sep 12, 2025
StartActual
Sep 2, 2025
Primary completionActual
Sep 20, 2025
CompletionActual
Sep 24, 2025
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Enrollment
36→30
Oct 7, 2026
Eligibility
Maximum age 45 Years→40 Years; 1 exclusion criterion added
What changed in the criteria
Exclusion criteria
  • AddedHistory of vertigo
Oct 26, 2026
Interventions
Arms added: Low load first·High load first; arms removed: Whole-Body Vibration in Healthy Volunteers
Oct 7, 2026
Secondary outcomes
2 added
What changed in the outcomes
  • AddedReflex persistence during whole-body vibrationTime frame: Day 1 (single-session, during each experimental condition)
  • AddedPhase-locking strength between the vibration cycle and the soleus reflex responseTime frame: Day 1 (single-session, during each experimental condition)
Oct 7, 2026
Show all 2 updates
  1. Oct 26, 2026
    Eligibility Maximum age 45 Years→40 Years; 1 exclusion criterion added
    What changed in the criteria
    Exclusion criteria
    • AddedHistory of vertigo
    + 2 other changes: verification date and description
  2. Oct 7, 2026
    Enrollment 36→30
    Secondary outcomes 2 added
    What changed in the outcomes
    • AddedReflex persistence during whole-body vibrationTime frame: Day 1 (single-session, during each experimental condition)
    • AddedPhase-locking strength between the vibration cycle and the soleus reflex responseTime frame: Day 1 (single-session, during each experimental condition)
    Interventions Arms added: Low load first·High load first; arms removed: Whole-Body Vibration in Healthy Volunteers
    + 1 other change: design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07170709
Lead sponsor
Selim Sezikli
Responsible party
Selim Sezikli (Principal Investigator / Physical Medicine & Rehabilitation Specialist, Istanbul Physical Medicine Rehabilitation Training and Research Hospital) — Sponsor-investigator
First posted
Sep 12, 2025
Start date
Sep 2, 2025
Primary completion
Sep 20, 2025
Completion
Sep 24, 2025
Last update
Oct 26, 2026

Study contacts

Selim Sezikli, MD
principal investigator · Istanbul Physical Medicine and Rehabilitation Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion